doi:10.1097/HNP.0000000000000528
This copper peptide gene regulation manifests in several clinically significant ways: Downregulation of Pro-Inflammatory Genes: It actively suppresses genes associated with inflammation, such as those in the IL-6 and NF-B pathways, which are major drivers of cellular aging
Noom can prescribe and distribute GLP-1 medication, as well as metformin (an oral diabetic drug associated with decreases in appetite and increases in satiety)
High glucose status and insulin resistance in diabetic patients promote cell metabolism disorders and release a large amount of reactive oxygen species, which in turn activates nuclear factor B, induces the expression of inflammatory factors, damages vascular endothelial cells, and causes abnormal proliferation of smooth muscle cells
Other effects, such as that of pain production, still require further elucidation